SEC Tracker
Get the app

Korsana Biosciences KRSA

Korsana Biosciences to resubmit redomestication

Proxy statement

Form
DEF 14A
Filed
Importance
Routine
  1. Special meeting on Nov 13, 2026
  2. Merger completed on Sep 8, 2026
  3. Redomestication failed in Aug 2026
  4. Board recommends approval of proposals

Written from the DEF 14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Korsana Biosciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX